Market Overview

40 Stocks Moving In Monday's Mid-Day Session

Share:

Gainers

  • Diffusion Pharmaceuticals Inc. (NASDAQ: DFFN) shares rose 65.1 percent to $4.7225 after the US Patent Office awarded the company exclusive rights for the use of its TSC drug in conjunction with tPA for stroke treatment.
  • Synergy Pharmaceuticals Inc. (NASDAQ: SGYP) climbed 34.2 percent to $0.1073 after Health Canada accepted Cipher Pharmaceuticals' new drug submission for PLECANATIDE.
  • Fidelity Southern Corporation (NASDAQ: LION) jumped 22.3 percent to $26.20 after the company and Ameris Bancorp (NASDAQ: ABCB) agreed to merge.
  • Evofem Biosciences, Inc. (NASDAQ: EVFM) shares climbed 19.7 percent to $4.19 after the company disclosed that its Phase 3 study evaluating amphora for hormone-free birth control met primary endpoint.
  • YRC Worldwide Inc. (NASDAQ: YRCW) gained 16.1 percent to $3.68.
  • NRC Group Holdings Corp. (NASDAQ: NRCG) shares rose 16 percent to $8.21.
  • Axovant Sciences Ltd. (NASDAQ: AXON) gained 14.5 percent to $1.1565. Jefferies upgraded Axovant Sciences from Hold to Buy.
  • Globalstar, Inc. (NYSE: GSAT) shares climbed 14.3 percent to $0.3428 after announcing an agreement with two hedge funds who were pushing for a strategic review of the company.
  • AgeX Therapeutics, Inc. (NYSE: AGE) shares gained 13.9 percent to $4.0425.
  • HyreCar Inc. (NASDAQ: HYRE) shares surged 13.2 percent to $2.40.
  • Proteostasis Therapeutics, Inc. (NASDAQ: PTI) gained 12.6 percent to $5.41 after reporting a global license agreement with Genentech.
  • Coeur Mining, Inc. (NYSE: CDE) gained 12.4 percent to $4.2922.
  • Axovant Sciences Ltd. (NASDAQ: AXON) rose 11.8 percent to $1.1287 after Jefferies upgraded the stock from hold to buy and raised its price target from $2.50 to $3 per share.
  • Uxin Limited (NASDAQ: UXIN) shares climbed 10.7 percent to $8.30.
  • Alamos Gold Inc. (NYSE: AGI) shares rose 10.1 percent to $3.27.
  • AudioEye, Inc. (NASDAQ: AEYE) climbed 10 percent to $7.70 after the company issued strong FY2019 sales forecast.
  • KCAP Financial Inc (NASDAQ: KCAP) gained 8.8 percent to $3.21 after announcing a stock purchase agreement with BC Partners.
  • Pretium Resources Inc. (NYSE: PVG) climbed 8.2 percent to $8.03.
  • The Madison Square Garden Company (NYSE: MSG) gained 6 percent to $276.91 after ESPN reported that Knicks owner James Dolan would consider selling team for a 'bona fide' offer.
  • BioXcel Therapeutics, Inc. (NASDAQ: BTAI) climbed 5.5 percent to $4.0500 after the CEO bought 2,000 shares at an average price of $4.38/share.
  • XPO Logistics, Inc. (NYSE: XPO) surged 4.8 percent to $54.03 after analysts at Barclays maintained an 'Overweight' rating on the stock.
  • Embraer SA (NYSE: ERJ) rose 3.8 percent to $21.93 after announcing Boeing would acquire 80% of the company for $4.2 billion.

 

Check out these big penny stock gainers and losers

Losers

  • Sophiris Bio, Inc. (NASDAQ: SPHS) shares dipped 42 percent to $1.1966 after announcing the company's phase 2b prostate cancer trial showed no additional benefit to patients.
  • Cancer Genetics Inc (NASDAQ: CGIX) dipped 36.4 percent to $0.3534 after the company terminated its proposed merger with NovellusDx.
  • Dova Pharmaceuticals, Inc. (NASDAQ: DOVA) tumbled 27 percent to $10.81. Dova Pharmaceuticals appointed David Zaccardelli as President and CEO. The company expects Q4 net poduct sales of $2.4 million to $2.7 million for DOPTELET.
  • LogicBio Therapeutics, Inc. (NASDAQ: LOGC) shares fell 21.2 percent to $7.26.
  • Overstock.com, Inc. (NASDAQ: OSTK) shares dropped 19.5 percent to $13.87. GSR Capital has engaged tZERO to develop commodity contract token.
  • Molina Healthcare, Inc. (NYSE: MOH) fell 14.3 percent to $112.95. Molina Healthcare disclosed that it is disappointed in the recent Affordable Care Act ruling by the US Court for the Northern District of Texas.
  • Alliqua BioMedical, Inc. (NASDAQ: ALQA) declined 13.9 percent to $2.3164 after climbing 26.29 percent on Friday.
  • Innovate Biopharmaceuticals, Inc. (NASDAQ: INNT) fell 13.1 percent to $2.46. Innovate Biopharmaceuticals announced plans to commence its Phase 3 registration trial in celiac disease in 1H 2019 and announce top-line NASH data with drug combinations by EASL 2019.
  • Achillion Pharmaceuticals, Inc. (NASDAQ: ACHN) fell 11.7 percent to $2.7450.
  • Adial Pharmaceuticals, Inc. (NASDAQ: ADIL) dropped 10.5 percent to $3.40.
  • Farfetch Limited (NASDAQ: FTCH) declined 10.4 percent to $21.40.
  • FAT Brands Inc. (NASDAQ: FAT) shares dipped 9.1 percent to $5.15.
  • Community Health Systems, Inc. (NYSE: CYH) shares dropped 8.6 percent to $3.5850. Health insurers and healthcare providers are trading down today after a Texas court ruled that ObamaCare was unconstitutional.
  • Neurotrope Inc (NASDAQ: NTRP) shares fell 8.5 percent to $4.00 after the company priced a stock and warrant offering at $4.495 per share.
  • Equillium, Inc. (NASDAQ: EQ) dipped 7.6 percent to $11.09.
  • PPDAI Group Inc. (NYSE: PPDF) fell 7.5 percent to $4.0600 after dropping 10.77 percent on Friday.
  • Centene Corporation (NYSE: CNC) fell 7.5 percent to $118.00 after declining 4.02 percent on Friday.
  • Tenet Healthcare Corporation (NYSE: THC) fell 6.8 percent to $19.81 after dropping 9.39 percent on Friday.

Posted-In: LosersNews Movers & Shakers Intraday Update Markets Movers Trading Ideas General

 

Related Articles (ABCB + ACHN)

View Comments and Join the Discussion!
Fastest Market News Application
You'll Hear It First On Pro
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Trading Daily
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Daily Analyst Rating
A summary of each day’s top rating changes from sell-side analysts on the street.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com

Credit Suisse Says Canada Goose Stock Pressure Appears Overdone

Positive Data From Orchard Therapeutics Turns Goldman Sachs Bullish